Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Investing

Pfizer : PFE

All Pfizer Articles

1501 Articles

Trey Thoelcke | Jul 27, 2020 at 7:15 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Chris Lange | Jul 22, 2020 at 10:04 AM EDT

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in…

Chris Lange | Jul 21, 2020 at 11:23 AM EDT

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than…

Chris Lange | Jul 20, 2020 at 9:52 AM EDT

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

BioNTech and Pfizer are leading the pack of COVID-19 vaccine stocks as this collaboration came out with more positive news…

Chris Lange | Jul 17, 2020 at 7:44 AM EDT

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street…

Chris Lange | Jul 13, 2020 at 11:31 AM EDT

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus…

Trey Thoelcke | Jul 13, 2020 at 7:39 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Jon C. Ogg | Jul 9, 2020 at 10:59 AM EDT

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

24/7 Wall St. has identified five defensive stocks that must greatly improve before they are deemed expensive or fully valued…

Chris Lange | Jul 8, 2020 at 10:52 AM EDT

Why Pfizer’s Stock Could Rise 60% or More

Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date?…

Chris Lange | Jul 7, 2020 at 8:55 AM EDT

5 Speculative COVID-19 Stocks That Could Still Surge

24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a…

Chris Lange | Jul 1, 2020 at 12:53 PM EDT

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

Pfizer and BioNTech have been collaborating to produce a messenger RNA based vaccine for the past few months, and this…

Trey Thoelcke | Jun 25, 2020 at 6:15 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | Jun 10, 2020 at 6:55 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 28, 2020 at 7:20 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks.

Trey Thoelcke | May 12, 2020 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks. The…

1 … 22 23 24 25 26 … 101

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted Dow Stocks

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

The 5 Most Shorted Dow Stocks

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

Why Pfizer’s Stock Could Rise 60% or More

5 Speculative COVID-19 Stocks That Could Still Surge

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

TSMC’s Winbond DRAM Deal Isn’t Domination, It’s Insurance. Here’s What It Actually Means for Chip ETFs

Slow Mornings on the French Riviera: Retire to the South of France at 62 on $1.1 Million

CrowdStrike Surges 5%, Palo Alto and Okta Gain 4% as Cybersecurity Stocks Rally on Analyst Upgrades

Slow Mornings on the French Riviera: Retire to the South of France at 62 on $1.1 Million

$1 Million Annuity Locks In $6,100 a Month for Life, but What Happens to Surviving Spouse?

TSMC’s Winbond DRAM Deal Isn’t Domination, It’s Insurance. Here’s What It Actually Means for Chip ETFs

Slow Mornings on the French Riviera: Retire to the South of France at 62 on $1.1 Million

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted Dow Stocks

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

8 Coronavirus Stocks That Can Deliver Even More Upside Ahead

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track

The 5 Most Shorted Dow Stocks

5 Undervalued Defensive Stocks Not Receiving Enough Credit for a Post-Coronavirus Recovery

Why Pfizer’s Stock Could Rise 60% or More

5 Speculative COVID-19 Stocks That Could Still Surge

Meet the New Frontrunners in the Race for a COVID-19 Vaccine

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

The 5 Most Shorted Dow Stocks

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

TSMC’s Winbond DRAM Deal Isn’t Domination, It’s Insurance. Here’s What It Actually Means for Chip ETFs

Slow Mornings on the French Riviera: Retire to the South of France at 62 on $1.1 Million

CrowdStrike Surges 5%, Palo Alto and Okta Gain 4% as Cybersecurity Stocks Rally on Analyst Upgrades

Featured Reads

Slow Mornings on the French Riviera: Retire to the South of France at 62 on $1.1 Million

$1 Million Annuity Locks In $6,100 a Month for Life, but What Happens to Surviving Spouse?